Tech Company Financing Transactions
Natera Funding Round
On 12/5/2007, Natera announced $4 million in Series A investment from Claremont Creek Ventures and Sequoia Capital.
Transaction Overview
Company Name
Announced On
12/5/2007
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Claremont Creek Ventures (Lead Investor) (John Steuart)
Sequoia Capital (Roelof Botha)
Proceeds Purpose
GSN will use the investment capital to commercialize its proprietary genetic screening technology.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
201 Industrial Rd. 410
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Website
Email Address
Overview
Natera (NASDAQ: NTRA) is a genetic testing company that has developed a proprietary bioinformatics technology to deliver accurate and comprehensive high throughput testing for reproductive indications from tiny quantities of DNA -- as small as that from a single cell.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Matthew Rabinowitz
Chief Executive Officer
Steve Chapman
Chief Financial Officer
Michael Brophy
Chief Technical Officer
Jonathan Sheena
VP - General Counsel
Daniel Rabinowitz
Browse more venture capital transactions:
Prev: 12/5/2007: Adapx venture capital transaction
Next: 12/5/2007: Evalve venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs